Table 3 Physician’s reasons not to perform alpha-1 antitrypsin deficiency test. Data show totally agreement in each question (n, %)
Spain | Portugal | P value | PUL | IMS | PCP | P value | Total | |
|---|---|---|---|---|---|---|---|---|
N = 170 | N = 138 | N = 55 | N = 91 | N = 162 | N = 308 | |||
Not available treatment | 11 (6.5) | 13 (9.4) | NS | 6 (10.9) | 10 (11.0) | 8 (4.9) | NS | 24 (7.8) |
Not having time | 20 (11.8) | 11 (8.0) | NS | 9 (16.0) | 4 (4.0) | 18 (11.0) | 0.016 | 31 (10.1) |
High economic cost | 77 (45.3) | 43 (31.2) | 0.011 | 22 (40.0) | 45 (49.5) | 53 (32.7) | 0.032 | 120 (39.0) |
Too long to receive results | 27 (15.9) | 10 (7.2) | 0.020 | 12 (21.8) | 11 (12.0) | 14 (8.6) | 0.034 | 37 (12.0) |
Not visiting any patient with AATD | 10 (5.9) | 39 (28.3) | <0.001 | 5 (9.0) | 17 (18.0) | 27 (16.7) | NS | 49 (15.9) |
Referred to other specialist | 59 (34.7) | 64 (46.4) | 0.038 | 11 (20.0) | 28 (30.0) | 84 (52.0) | 0.001 | 123 (39.9) |
Any positive determination | 23 (13.5) | 2 (1.4) | <0.001 | 6 (10.0) | 11 (12.0) | 8 (5.0) | NS | 25 (8.1) |
Unclear interpretation of results | 14 (8.2) | 9 (6.5) | NS | 4 (7.0) | 6 (6.0) | 13 (8.0) | NS | 23 (7.5) |
Other | 31 (18.2) | 25 (18.1) | NS | 14 (25.5) | 18 (19.0) | 24 (14.8) | NS | 56 (18.2) |